BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 28786882)

  • 1. How can the cystic fibrosis respiratory microbiome influence our clinical decision-making?
    Rogers GB; Bruce KD; Hoffman LR
    Curr Opin Pulm Med; 2017 Nov; 23(6):536-543. PubMed ID: 28786882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Insights into Pulmonary Exacerbations in Cystic Fibrosis from the Microbiome. What Are We Missing?
    Whelan FJ; Surette MG
    Ann Am Thorac Soc; 2015 Nov; 12 Suppl 2():S207-11. PubMed ID: 26595741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deciphering the Ecology of Cystic Fibrosis Bacterial Communities: Towards Systems-Level Integration.
    Bevivino A; Bacci G; Drevinek P; Nelson MT; Hoffman L; Mengoni A
    Trends Mol Med; 2019 Dec; 25(12):1110-1122. PubMed ID: 31439509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cystic fibrosis respiratory microbiota: unraveling complexity to inform clinical practice.
    Caverly LJ; LiPuma JJ
    Expert Rev Respir Med; 2018 Oct; 12(10):857-865. PubMed ID: 30118374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cystic fibrosis lung microbiome: opportunities to reconsider management of airway infection.
    Caverly LJ; Zhao J; LiPuma JJ
    Pediatr Pulmonol; 2015 Oct; 50 Suppl 40():S31-8. PubMed ID: 26335953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring clinical and microbiological evolution of a cystic fibrosis patient over 26 years: experience of a Brazilian CF Centre.
    da Costa Ferreira Leite C; Folescu TW; de Cássia Firmida M; Cohen RWF; Leão RS; de Freitas FAD; Albano RM; da Costa CH; Marques EA
    BMC Pulm Med; 2017 Jul; 17(1):100. PubMed ID: 28705217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystic fibrosis lung environment and Pseudomonas aeruginosa infection.
    Bhagirath AY; Li Y; Somayajula D; Dadashi M; Badr S; Duan K
    BMC Pulm Med; 2016 Dec; 16(1):174. PubMed ID: 27919253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of the respiratory tract microbiota in cystic fibrosis.
    de Koff EM; de Winter – de Groot KM; Bogaert D
    Curr Opin Pulm Med; 2016 Nov; 22(6):623-8. PubMed ID: 27583669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of the respiratory tract microbiota in cystic fibrosis.
    de Koff EM; Groot KM; Bogaert D
    Curr Opin Pulm Med; 2016 Nov; 22(6):623-628. PubMed ID: 27841789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The lower airway microbiota in early cystic fibrosis lung disease: a longitudinal analysis.
    Frayman KB; Armstrong DS; Carzino R; Ferkol TW; Grimwood K; Storch GA; Teo SM; Wylie KM; Ranganathan SC
    Thorax; 2017 Dec; 72(12):1104-1112. PubMed ID: 28280235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Microbiome in Cystic Fibrosis.
    Huang YJ; LiPuma JJ
    Clin Chest Med; 2016 Mar; 37(1):59-67. PubMed ID: 26857768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Lung Microbiome and Airway Disease.
    Lynch SV
    Ann Am Thorac Soc; 2016 Dec; 13 Suppl 2(Suppl 5):S462-S465. PubMed ID: 28005424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbiome in cystic fibrosis: Shaping polymicrobial interactions for advances in antibiotic therapy.
    Lopes SP; Azevedo NF; Pereira MO
    Crit Rev Microbiol; 2015; 41(3):353-65. PubMed ID: 24645634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expanding our understanding of respiratory microbiota in cystic fibrosis.
    LiPuma JJ
    Ann Am Thorac Soc; 2014 Sep; 11(7):1084-5. PubMed ID: 25237989
    [No Abstract]   [Full Text] [Related]  

  • 15. Different next generation sequencing platforms produce different microbial profiles and diversity in cystic fibrosis sputum.
    Hahn A; Sanyal A; Perez GF; Colberg-Poley AM; Campos J; Rose MC; Pérez-Losada M
    J Microbiol Methods; 2016 Nov; 130():95-99. PubMed ID: 27609714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The lung and gut microbiome: what has to be taken into consideration for cystic fibrosis?
    Héry-Arnaud G; Boutin S; Cuthbertson L; Elborn SJ; Tunney MM
    J Cyst Fibros; 2019 Jan; 18(1):13-21. PubMed ID: 30487080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The microbiome and emerging pathogens in cystic fibrosis and non-cystic fibrosis bronchiectasis.
    Green H; Jones AM
    Semin Respir Crit Care Med; 2015 Apr; 36(2):225-35. PubMed ID: 25826590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The lung microbiome in 2015: a window on chronic lung diseases].
    Andréjak C; Delhaes L
    Med Sci (Paris); 2015 Nov; 31(11):971-8. PubMed ID: 26576604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbiome in the pathogenesis of cystic fibrosis and lung transplant-related disease.
    Cribbs SK; Beck JM
    Transl Res; 2017 Jan; 179():84-96. PubMed ID: 27559681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The evolving dynamics of the microbial community in the cystic fibrosis lung.
    McGuigan L; Callaghan M
    Environ Microbiol; 2015 Jan; 17(1):16-28. PubMed ID: 24801013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.